SHANNON MARTIN: Open Payments
NPI 1962001818 · CUMBERLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 28 payments from 4 companies in 2025. Trend: 2023 $624 · 2024 $658 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $348 |
| AstraZeneca Pharmaceuticals LP | 5 | $86 |
| UCB, Inc. | 1 | $27 |
| Amgen Inc. | 1 | $14 |
Products named: VRAYLAR, AIRSUPRA, QULIPTA, Briviact, BREZTRI, KRYSTEXXA, UBRELVY.
Industry payments across MD — which companies pay providers there.
